Insilico Medicine and Takeda Form $600 Million AI Drug Discovery Partnership
Insilico Medicine and Takeda have announced a collaboration to use Insilico’s Pharma.AI platform for identifying and developing novel drug candidates. The agreement could reach a total value of about $600 million, including upfront and milestone payments.